Abstract 234: Prior Warfarin Treatment and Intracranial Hemorrhage among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: A Meta-analysis [Poster Session II]
Conclusions: These data suggested that the risk of sICH after thrombolytic therapy is not increased in patients using warfarin with sub therapeutic INR levels.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Li, H., Xian, Y., Laskowitz, D., Peterson, E. Tags: Poster Session II Source Type: research
More News: Bleeding | Cardiology | Cardiovascular | Coumadin | Databases & Libraries | Heart | Hemorrhagic Stroke | Ischemic Stroke | Science | Stroke | Study | Thrombolytic Therapy | Thrombosis | Warfarin